Dyrk1A Antibodies

Santa Cruz Biotechnology features a diverse variety of Dyrk1A monoclonal antibodies for investigating Dyrk1A's role in various biological processes. Multiple detection methods are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Dyrk1A, a member of the dual-specificity tyrosine phosphorylation-regulated kinase family, plays a crucial role in cellular signaling pathways and is implicated in neurodevelopmental processes. Dyrk1A dysregulation has been associated with various conditions, including Down syndrome and other neurodegenerative diseases, highlighting its significance in both health and disease. Research focused on Dyrk1A can provide valuable insights into potential therapeutic targets for neurological conditions. Investigating Dyrk1A expression patterns helps reveal its involvement in cell cycle regulation and neuronal differentiation. Understanding Dyrk1A's molecular mechanisms can advance knowledge about brain development and cognitive function. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of Dyrk1A's role in human health and disease progression.